Dantron
Overview
Categories
- 17 Gastrointestinal drugs
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Dantron's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 8 mg | 8 (8) | As recommended. | PO | For patients receiving emetogenic chemotherapy or radiotherapy: This dose should be administered 1-2 hours before treatment, followed by 8 mg orally twelve hourly. |
| 16 mg | 16 (16) | As recommended. | PO | For the prevention of post-operative nausea and vomiting: This dose should be given one hour prior to induction of anaesthesia. |
| 25 to 75 mg | 50 (50) | As recommended. | PO | When given as co-danthramer with poloxamer. |
| 50 to 150 mg | 100 (100) | As recommended. | PO | When given as co-danthrusate with dowsate sodium. |
Paedriatic Dosage (20kg)
|
| 25 to 12.5 mg | 19 (18.75) | As recommended. | P/O | Age 12 or above. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Dantron is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Dantron
Back to top
Previous Drug Generic - Next Drug Generic